SGM-1019

N/A

Report date: 2022/11/25 17:24:29
NME

Base Information

Drug NameSGM-1019
Drug Alias NameSGM-1019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetagenome modulators
TargetsMetagenome
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSecond Genome Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSecond Genome Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A